Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Revive Therapeutics Ltd
C.RVV
Alternate Symbol(s):
RVVTF
Healthcare
Biotechnology
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is...
evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
CSE:RVV - Post Discussion
Revive Therapeutics Ltd
> FDA may authorize COVID-19 vaccine for kids 2 months Data ?
New Post
View:
Discussion
List
(3)
•••
cool888
X
View Profile
View Bullboard History
Post by
cool888
on Sep 10, 2021 8:29pm
FDA may authorize COVID-19 vaccine for kids 2 months Data ?
What a Fuc**ng JOKE ! Here we have Bucillamine with 30 year safety was REPURPOSED for Covid 19, have been on TRIALS for almost an YEAR with atleast 400 to 600 participants and more maybe, didn't have any issues (one would think, otherwise it would have been stopped) and here with ONLY two months trials (don't beleive so, anyways) FDA to APPROVE for KIDS. REALLY !
https://www.news10.com/news/fda-may-authorize-covid-19-vaccine-for-kids-based-on-two-months-of-safety-da
ta
God Bless (less) America ! in my opinion, one of the worst corrupt country in the WORLD.
Folks, I was in the Middle East for 7 Years in Dubai, during Lebanon war, Shah of Iran stuff.
Don't want to go further. Have a great weekends folks.
Best ORAL for Covid 19 - Bucillamine but yet to get approved, Just Big Time Corruption at the Higher Levels arounf FDA, CDC & White House.
Hope, INDIA could take the lead and EUA Bucillamine NOW. (Again, same old story)
(172)
•••
MyAli4s
X
View Profile
View Bullboard History
Comment by
MyAli4s
on Sep 10, 2021 10:24pm
This post has been removed in accordance with Community Policy
(48)
•••
Billy111
X
View Profile
View Bullboard History
Comment by
Billy111
on Sep 11, 2021 12:21pm
They aren't touching my kids with that bullsh## f##k off fda
(3)
•••
cool888
X
View Profile
View Bullboard History
Comment by
cool888
on Sep 11, 2021 8:52pm
We DO NOT know for sure, BUT, someone knows for SURE, just be PATIENCE !! It appears all going in our favour, very soon hopefully ! WORLD needs a Covid Pill and BUC must be #1 WITHOUT Political/Big Pharma interferences !! Lots of people DO NOT trust Vaccines and am sure will ready to take a PILL. Read below, how people are so desparate for a PILL instead of Vaccine. https://www.news24.com
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Do you want to stay ahead of the markets? See how DealRoom can help.